IBM stock gains 3.01 percent as IBM reaches Stage C
IBM stock gains 3.01 percent as IBM reaches Stage C AD HOC NEWS
Covered in this story
Analyst targets on IBM
- Truist Securities: $227 → $240 by Oct 2027 via Pluang
- Barclays: $234 → $350 by Aug 2027 · Overweight via foreignpolicyjournal.com
- Citi: $214 → $245 by Jul 2027 · Buy via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Dalsna Finance is currently tracking 50 stories mentioning IBM, the earliest published 12 Aug 2026.
Summary aggregated from AD HOC NEWS's public RSS feed. The full reporting belongs to AD HOC NEWS — please read it on their site.